PTC Therapeutics
PTCT
PTCT
184 hedge funds and large institutions have $2.09B invested in PTC Therapeutics in 2019 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 69 increasing their positions, 55 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.69% more ownership
Funds ownership: 99.91% → 100.6% (+0.69%)
20% less capital invested
Capital invested by funds: $2.63B → $2.09B (-$532M)
22% less funds holding in top 10
Funds holding in top 10: 9 → 7 (-2)
Holders
184
Holding in Top 10
7
Calls
$39.3M
Puts
$28.4M
Top Buyers
| 1 | +$55.9M | |
| 2 | +$42M | |
| 3 | +$17.4M | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$15.7M |
| 5 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$13.1M |
Top Sellers
| 1 | -$35M | |
| 2 | -$8.92M | |
| 3 | -$8.08M | |
| 4 |
Renaissance Technologies
New York
|
-$8.08M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$6.18M |